Peregrine Capital Management LLC Dynavax Technologies Corp Transaction History
Peregrine Capital Management LLC
- $3.18 Billion
- Q4 2024
A detailed history of Peregrine Capital Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 654,620 shares of DVAX stock, worth $8.79 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
654,620
Previous 642,933
1.82%
Holding current value
$8.79 Million
Previous $7.16 Million
16.71%
% of portfolio
0.26%
Previous 0.22%
Shares
7 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$294 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$239 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$123 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$105 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$88 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.7B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...